Opin vísindi
How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers
- Opin vísindi
- →
- Háskóli Íslands
- →
- Greinar- HÍ
- →
- Skoða verk
JavaScript is disabled for your browser. Some features of this site may not work without it.
| Titill: | How do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registers |
| Höfundur: |
... 5 fleiri höfundar Sýna alla höfunda |
| Útgáfa: | 2020-09-08 |
| Tungumál: | Enska |
| Umfang: | e001363 |
| Háskóli/Stofnun: | Háskóli Íslands University of Iceland |
| Svið: | Heilbrigðisvísindasvið (HÍ) School of Health Sciences (UI) |
| Deild: | Læknadeild (HÍ) Faculty of Medicine (UI) |
| Birtist í: | RMD Open;6(2) |
| ISSN: | 2056-5933 |
| DOI: | 10.1136/rmdopen-2020-001363 |
| Efnisorð: | Arthritis; Biological Therapy; Epidemiology; Rheumatoid; Iktsýki; Líftæknilyf |
| URI: | https://hdl.handle.net/20.500.11815/2202 |
Tilvitnun:Chatzidionysiou K, Delcoigne B, Frisell T, et alHow do we use biologics in rheumatoid arthritis patients with a history of malignancy? An assessment of treatment patterns using Scandinavian registersRMD Open 2020;6:e001363. doi: 10.1136/rmdopen-2020-001363
|
|
Útdráttur:[No abstract available]
|
|
Athugasemdir:Publisher's version (útgefin grein)
|
|
Leyfi:This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
|
|
Skrár
Þetta verk birtist í eftirfarandi safni/söfnum:
-
Greinar- HÍ
Articles